Creative Destruction Lab (CDL) — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Axiom Therapeuticsaxiom-therapeutics.comAug 2026

Axiom Therapeutics runs a drug discovery platform for covalent inhibitors, applying machine learning to speed up physics-based simulations.

BiotechLondon, GB

Ryan Geiser(CEO)in Chris Haggard(CTO)inSofia Dahoune(Director)

Co-investorsEntrepreneur First Lunar Ventures Samos Investments Transpose Platform Management Verve Ventures University of Cambridge Enterprise

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.